Aktis Oncology
Latest round
- Series B
Last raised
- Sep 2024
Total raised
- $331M
Investors
- 20
About Aktis Oncology
Aktis Oncology, Inc., founded in 2021, is based in Boston, US. The company specializes in precision radiopharmaceuticals designed to target cancer cells specifically.Aktis Oncology specializes in the development of precision radiopharmaceuticals that leverage advanced platform technologies to deliver targeted therapies. Key offerings include alpha-emitting particles aimed at precisely targeting cancer cells, enhancing treatment options for patients with prevalent cancers.Aktis Oncology generates revenue through collaborations with healthcare institutions and oncology clinics that utilize its precision radiopharmaceuticals. The company engages in direct sales agreements with hospitals and cancer treatment centers, which include ongoing support and training for medical staff.In September 2024, Aktis Oncology, Inc. The company plans to design and launch new products to enhance its therapeutic offerings, targeting an expansion into additional markets in North America and Europe.
Who invested in Aktis Oncology
20 investors across 3 rounds
See all investors in Aktis Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aktis Oncology
Who invested in Aktis Oncology?
Aktis Oncology has 20 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aktis Oncology raised?
Aktis Oncology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aktis Oncology last raise money?
Aktis Oncology's most recent round on record is a Series B, in Sep 2024.
What does Aktis Oncology do?
Aktis Oncology is a biotechnology company.
Where is Aktis Oncology headquartered?
Aktis Oncology is headquartered in Boston, US.
Which VCs invest in companies like Aktis Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aktis Oncology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Aktis Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.